scholarly article | Q13442814 |
P50 | author | Michael Saag | Q6834090 |
Jeroan J. Allison | Q37386090 | ||
Gim Gee Teng | Q58447554 | ||
Jeffrey R Curtis | Q87706464 | ||
P2093 | author name string | Kenneth G Saag | |
Nivedita M Patkar | |||
Carolyn Martin | |||
P2860 | cites work | Does This Adult Patient Have Acute Meningitis? | Q22918880 |
Predicting acute maxillary sinusitis in a general practice population | Q24645520 | ||
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 | ||
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference | Q29618757 | ||
Accuracy of administrative data for identifying patients with pneumonia | Q31017040 | ||
Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. | Q34149655 | ||
Synovial fluid tests. What should be ordered? | Q34222546 | ||
Assessment of diagnostic tests when disease verification is subject to selection bias | Q34272301 | ||
New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service | Q34339285 | ||
Acute diverticulitis under age forty | Q34728155 | ||
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study | Q34923104 | ||
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. | Q35094247 | ||
Infectious complications of treatment with biologic agents | Q35807989 | ||
Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors. | Q36101689 | ||
A review of uses of health care utilization databases for epidemiologic research on therapeutics | Q36111277 | ||
Bias in the coding of hospital discharge data and its implications for quality assessment | Q36759497 | ||
Bacterial osteomyelitis: findings on plain radiography, CT, MR, and scintigraphy | Q37185661 | ||
Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease | Q39121113 | ||
Contamination of catheter-drawn blood cultures | Q39466282 | ||
Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen | Q39655731 | ||
Osteomyelitis: A Review of Clinical Features, Therapeutic Considerations and Unusual Aspects | Q39986155 | ||
Value of routine stool cultures in hospitalized patients with diarrhea | Q40467959 | ||
Etiology of bloody diarrhea among patients presenting to United States emergency departments: prevalence of Escherichia coli O157:H7 and other enteropathogens | Q40608752 | ||
Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features | Q40653214 | ||
A Semiquantitative Culture Method for Identifying Intravenous-Catheter-Related Infection | Q40767561 | ||
Diagnostic value of sinus-tract cultures in chronic osteomyelitis | Q40891778 | ||
International Classification of Diseases, 9th Revision, Clinical Modification codes in discharge abstracts are poor measures of complication occurrence in medical inpatients | Q41505912 | ||
A practical guide for the diagnosis and treatment of acute sinusitis. | Q41624071 | ||
Pyogenic hepatic abscess. Changing trends over 42 years | Q42631355 | ||
The prevention and management of device-related infection in infusion therapy | Q43627292 | ||
Veteran's affairs hospital discharge databases coded serious bacterial infections accurately | Q43879445 | ||
Diverticulitis of the cecum and ascending colon | Q44588584 | ||
Infections in patients with rheumatoid arthritis treated with biologic agents | Q44952372 | ||
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy | Q46919825 | ||
Spectrum of cholangitis | Q50155971 | ||
Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography. | Q52892875 | ||
Predictive Value of Cerebrospinal Fluid (CSF) Lactate Level Versus CSF/Blood Glucose Ratio for the Diagnosis of Bacterial Meningitis Following Neurosurgery | Q57253186 | ||
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists | Q58974447 | ||
Acute cholangitis | Q67927240 | ||
Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects | Q68702835 | ||
Reliability of blood cultures collected from intravascular catheter versus venipuncture | Q69104738 | ||
Accuracy of cultures of material from swabbing of the superficial aspect of the wound and needle biopsy in the preoperative assessment of osteomyelitis | Q70178920 | ||
Erythrocyte sedimentation rate and C reactive protein in the assessment of suspected bone infection--are they reliable indices? | Q71082788 | ||
Choledocholithiasis: comparison of MR cholangiography and endoscopic retrograde cholangiography | Q71134315 | ||
Infection in rheumatoid arthritis | Q71754727 | ||
Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients | Q72539500 | ||
A new method for identifying antibiotic-treated infections using automated pharmacy records | Q73068083 | ||
Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer | Q73217604 | ||
Helical CT with only colonic contrast material for diagnosing diverticulitis: prospective evaluation of 150 patients | Q74604741 | ||
Primary liver abscess due to Klebsiella pneumoniae in Taiwan | Q74687282 | ||
Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis | Q80388423 | ||
Systemic inflammatory response syndrome (SIRS) definition and correlation with early-onset bacterial infection of the newborn | Q83192776 | ||
P4510 | describes a project that uses | Bayes' theorem | Q182505 |
P433 | issue | 3 | |
P921 | main subject | patient | Q181600 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 321-7, 327.e1-7 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | Journal of Clinical Epidemiology | Q6294959 |
P1476 | title | Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients | |
P478 | volume | 62 |
Q33704169 | A Comparison of Methods to Detect Urinary Tract Infections Using Electronic Data |
Q34216770 | A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries |
Q35498610 | A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis |
Q30713544 | A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data |
Q89477285 | An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data |
Q43592411 | Bloodstream infections in patients receiving manufactured parenteral nutrition with vs without lipids: is the use of lipids really deleterious? |
Q37347229 | Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014. |
Q35893859 | Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011. |
Q39626312 | Characteristics and current practice of parenteral nutrition in hospitalized patients |
Q40553708 | Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications. |
Q40598586 | Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare |
Q39296189 | Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study |
Q35899264 | Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics? |
Q38186563 | Databases and registers: useful tools for research, no studies |
Q35840753 | Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis |
Q34503439 | Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia® (denosumab) for the treatment of postmenopausal osteoporosis |
Q37341114 | Efficiency of International Classification of Diseases, Ninth Revision, billing code searches to identify emergency department visits for blood or body fluid exposures through a statewide multicenter database. |
Q35129370 | How well do discharge diagnoses identify hospitalised patients with community-acquired infections?--a validation study. |
Q90919802 | Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis |
Q36191250 | Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases |
Q37860842 | Leveraging electronic medical records for surveillance of surgical site infection in a total joint replacement population |
Q35677387 | Low Completeness of Bacteraemia Registration in the Danish National Patient Registry |
Q36150089 | Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting System |
Q36131029 | Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment |
Q90665225 | Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study |
Q87965698 | Risk of Serious Infection, Opportunistic Infection, and Herpes Zoster among Patients with Psoriasis in the United Kingdom |
Q35636624 | Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy |
Q37330765 | Risk of hospitalized bacterial infections associated with biologic treatment among US veterans with rheumatoid arthritis. |
Q41362251 | Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab |
Q40242247 | Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis |
Q34555474 | Systematic review of validation studies of the use of administrative data to identify serious infections |
Q28545832 | TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits |
Q35082559 | The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agents |
Q37274470 | The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis. |
Q36942914 | Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients |
Q55297765 | Validation of discharge diagnosis codes to identify serious infections among middle age and older adults. |
Q47574418 | Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs. |
Q37347648 | Validity of physician-reported hospitalized infections in a US arthritis registry |
Search more.